chevron_leftBack
As of 13 June 2026, Stella Diagnostics, Inc. has a market cap of $4.82M USD, ranking #44617 globally and #5687 in the United States.
It ranks #3951 in the Healthcare sector, and #836 in the Medical Devices industry.
Key Stats
Market Cap
$4.82MUSD
Net Income (TTM)
-$257.97KUSD
PB Ratio
-25.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
David Seaburg
open_in_new
Employees
2
Website
stelladx.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 14% | -26% | 3.2% | -43% | -9.5% | -63% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SLDX
Stella Diagnostics Inc
ISIN: US85853Y1047
Shares Out.:
Shares Outstanding:
301.505M1
Shares Float:
66.879M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0160 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Stella Diagnostics, Inc.
Stella Diagnostics, Inc., a research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases. It uses targeted mass spectrometry to determine the level of disease progression in tissue of the lower esophagus. The company’s technology informs gastroenterologists, surgical oncologists, and pathologists, which patients are high risk for disease progression into precancer or cancer. The company was formerly known as JMP Properties, Inc. and changed its name to Stella Diagnostics, Inc. in April 2021. Stella Diagnostics, Inc. is headquartered in Salt Lake City, Utah.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
4M%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
3M%
|
56.7
|
|
NYSE: ABT
|
$159.07B
3M%
|
25.6
|
|
NYSE: DHR
|
$126.55B
3M%
|
34.7
|
|
NYSE: SYK
|
$120.69B
3M%
|
38.3
|
|
NYSE: BSX
|
$84.93B
2M%
|
24.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: MDT
|
$101.9B
2M%
|
22.2
|
|
EPA: EL
|
$97.46B
2M%
84.32B EUR
|
36.7
|
|
TSE: 7741
|
$61.41B
1M%
9.83T JPY
|
40.0
|
|
XETRA: SHL
|
$45.47B
942K%
39.34B EUR
|
18.7
|
|
SIX: ALC
|
$36.38B
754K%
28.99B CHF
|
37.9
|
|
|
$30.06B
623K%
203.66B CNY
|
26.0
|
chevron_leftBack